Company Profiles

driven by the PitchBook Platform

Impel NeuroPharma

Description

Developer of next generation therapeutics for central nervous system disorders. The company has developed a novel drug delivery platform, the POD technology that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. It also provides treatment for Alzheimer's, Parkinson's, Migraine, and other high need CNS diseases.

2008

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$36M

Latest Deal Amount

$45.1M

Total Amount Raised

Description

Developer of next generation therapeutics for central nervous system disorders. The company has developed a novel drug delivery platform, the POD technology that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. It also provides treatment for Alzheimer's, Parkinson's, Migraine, and other high need CNS diseases.

Website:

www.impelnp.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Medical Supplies

Other Industries

Other Healthcare Technology Systems
Therapeutic Devices
Drug Delivery

Primary Office

915 East Pine Street Suite 404 Seattle, WA 98122United States +1 (206) 568-1466
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Impel NeuroPharma's full profile, request a free trial.

Impel NeuroPharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Impel NeuroPharma Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Impel NeuroPharma Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
3M New VenturesCorporate Venture CapitalMinority000 0000000 0000
5AM VenturesVenture CapitalMinority000 0000000 0000
Alliance of AngelsAngel GroupMinority000 0000000 0000
Life Science Discovery FundVenture CapitalMinority000 0000000 0000
United States Department of DefenseGovernmentMinority000 0000000 0000
3M New Ventures Corporate Venture Capital
5AM Ventures Venture Capital
Alliance of Angels Angel Group
Life Science Discovery Fund Venture Capital
United States Department of Defense Government

Impel NeuroPharma Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Michael HiteChief Executive Officer & Co-Founder
John Hoekman Ph.DCo-Founder, Chief Scientific Officer & Board Member
Paul Jenkins Ph.DDirector, Business Development
Matt TomsonDirector of Finance
Scott YoumansSenior Vice President, Engineering
Michael Hite Chief Executive Officer & Co-Founder
John Hoekman Ph.D Co-Founder, Chief Scientific Officer & Board Member
Paul Jenkins Ph.D Director, Business Development
Matt Tomson Director of Finance
Scott Youmans Senior Vice President, Engineering

Impel NeuroPharma Board Members (3)

NameRepresentingRoleSinceContact
Info
John Hoekman Ph.DImpel NeuroPharmaCo-Founder, Chief Scientific Officer & Board Member000 0000
Perry Fell Ph.DSelfBoard Member000 0000
Timothy NelsonSelfIndependent Director000 0000
John Hoekman Ph.D Co-Founder, Chief Scientific Officer & Board Member Impel NeuroPharma
Perry Fell Ph.D Board Member Self
Timothy Nelson Independent Director Self
Request full access to PitchBook